UK Markets closed

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.5800-0.1500 (-4.02%)
At close: 04:00PM EST
3.5900 +0.01 (+0.28%)
After hours: 04:10PM EST
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4556
Avg. Estimate-0.26-0.26-0.98-1
Low estimate-0.27-0.28-1.03-1.15
High estimate-0.26-0.25-0.81-0.8
Year ago EPS-0.24-0.24-0.9-0.98
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7768
Avg. Estimate1.37M2.01M5.21M15.32M
Low estimateN/AN/A3.53MN/A
High estimate4.5M8.7M8.5M41.5M
Year ago sales1.19M1.5M3.96M5.21M
Sales growth (year/est)14.80%33.80%31.60%194.00%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-0.25-0.23-0.25-0.24
Actual EPS-0.24-0.24-0.24-0.24
Difference0.01-0.010.010
Surprise %4.00%-4.30%4.00%0.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.26-0.26-0.98-1
7 days ago-0.27-0.27-1.02-1.05
30 days ago-0.27-0.27-1.02-1.05
60 days ago-0.25-0.25-0.98-1.01
90 days ago-0.25-0.25-0.98-1.01
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 days1122
Up last 30 days1122
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesADAPIndustrySector(s)S&P 500
Current qtr.-8.30%N/AN/AN/A
Next qtr.-8.30%N/AN/AN/A
Current year-8.90%N/AN/AN/A
Next year-2.00%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A